237 related articles for article (PubMed ID: 28531272)
1. A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer.
Good CR; Madzo J; Patel B; Maegawa S; Engel N; Jelinek J; Issa JJ
Nucleic Acids Res; 2017 Aug; 45(14):8269-8281. PubMed ID: 28531272
[TBL] [Abstract][Full Text] [Related]
2. TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cells.
Jin C; Lu Y; Jelinek J; Liang S; Estecio MR; Barton MC; Issa JP
Nucleic Acids Res; 2014 Jun; 42(11):6956-71. PubMed ID: 24875481
[TBL] [Abstract][Full Text] [Related]
3. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
[TBL] [Abstract][Full Text] [Related]
4. Isoform Switch of TET1 Regulates DNA Demethylation and Mouse Development.
Zhang W; Xia W; Wang Q; Towers AJ; Chen J; Gao R; Zhang Y; Yen CA; Lee AY; Li Y; Zhou C; Liu K; Zhang J; Gu TP; Chen X; Chang Z; Leung D; Gao S; Jiang YH; Xie W
Mol Cell; 2016 Dec; 64(6):1062-1073. PubMed ID: 27916660
[TBL] [Abstract][Full Text] [Related]
5. Different binding properties and function of CXXC zinc finger domains in Dnmt1 and Tet1.
Frauer C; Rottach A; Meilinger D; Bultmann S; Fellinger K; Hasenöder S; Wang M; Qin W; Söding J; Spada F; Leonhardt H
PLoS One; 2011 Feb; 6(2):e16627. PubMed ID: 21311766
[TBL] [Abstract][Full Text] [Related]
6. Methyl-CpG binding domain protein 1 regulates localization and activity of Tet1 in a CXXC3 domain-dependent manner.
Zhang P; Rausch C; Hastert FD; Boneva B; Filatova A; Patil SJ; Nuber UA; Gao Y; Zhao X; Cardoso MC
Nucleic Acids Res; 2017 Jul; 45(12):7118-7136. PubMed ID: 28449087
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells.
Xu Y; Wu F; Tan L; Kong L; Xiong L; Deng J; Barbera AJ; Zheng L; Zhang H; Huang S; Min J; Nicholson T; Chen T; Xu G; Shi Y; Zhang K; Shi YG
Mol Cell; 2011 May; 42(4):451-64. PubMed ID: 21514197
[TBL] [Abstract][Full Text] [Related]
8. Single-molecule multiplexed profiling of protein-DNA complexes using magnetic tweezers.
Liang L; Wang Z; Qu L; Huang W; Guo S; Guan X; Zhang W; Sun F; Yuan H; Zou H; Liu H; Yu Z
J Biol Chem; 2021; 296():100327. PubMed ID: 33493518
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
[TBL] [Abstract][Full Text] [Related]
10. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
[TBL] [Abstract][Full Text] [Related]
11. Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation.
Sohni A; Bartoccetti M; Khoueiry R; Spans L; Vande Velde J; De Troyer L; Pulakanti K; Claessens F; Rao S; Koh KP
Mol Cell Biol; 2015 Mar; 35(6):1026-42. PubMed ID: 25582196
[TBL] [Abstract][Full Text] [Related]
12. Putative promoters within gene bodies control exon expression via TET1-mediated H3K36 methylation.
Ma L; Muhammad T; Wang H; Du G; Sakhawat A; Wei Y; Ali Khan A; Cong X; Huang Y
J Cell Physiol; 2020 Oct; 235(10):6711-6724. PubMed ID: 31994732
[TBL] [Abstract][Full Text] [Related]
13. TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator.
Tsai YP; Chen HF; Chen SY; Cheng WC; Wang HW; Shen ZJ; Song C; Teng SC; He C; Wu KJ
Genome Biol; 2014 Dec; 15(12):513. PubMed ID: 25517638
[TBL] [Abstract][Full Text] [Related]
14. GADD45A binds R-loops and recruits TET1 to CpG island promoters.
Arab K; Karaulanov E; Musheev M; Trnka P; Schäfer A; Grummt I; Niehrs C
Nat Genet; 2019 Feb; 51(2):217-223. PubMed ID: 30617255
[TBL] [Abstract][Full Text] [Related]
15. Targeted TET oxidase activity through methyl-CpG-binding domain extensively suppresses cancer cell proliferation.
Mizuguchi Y; Saiki Y; Horii A; Fukushige S
Cancer Med; 2016 Sep; 5(9):2522-33. PubMed ID: 27457352
[TBL] [Abstract][Full Text] [Related]
16. TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
Kai M; Niinuma T; Kitajima H; Yamamoto E; Harada T; Aoki H; Maruyama R; Toyota M; Sasaki Y; Sugai T; Tokino T; Nakase H; Suzuki H
PLoS One; 2016; 11(12):e0168281. PubMed ID: 27977763
[TBL] [Abstract][Full Text] [Related]
17. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
[TBL] [Abstract][Full Text] [Related]
18. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity.
Williams K; Christensen J; Pedersen MT; Johansen JV; Cloos PA; Rappsilber J; Helin K
Nature; 2011 May; 473(7347):343-8. PubMed ID: 21490601
[TBL] [Abstract][Full Text] [Related]
19. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
20. Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer.
Thomson JP; Ottaviano R; Unterberger EB; Lempiäinen H; Muller A; Terranova R; Illingworth RS; Webb S; Kerr AR; Lyall MJ; Drake AJ; Wolf CR; Moggs JG; Schwarz M; Meehan RR
Cancer Res; 2016 May; 76(10):3097-108. PubMed ID: 27197233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
